First issue of IFFIm vaccine bonds announced for 2010
First issue of IFFIm vaccine bonds announced for 2010
1 March 2010
Daiwa Securities Group, the International Finance Facility for Immunisation Company ("IFFIm"), the GAVI Alliance, and the World Bank have announced today IFFIm's first issue of "Vaccine Bonds" for 2010.
The International Finance Facility for Immunisation's (IFFIm) first issue of "Vaccine Bonds" for 2010 is offered to Japanese retail investors investors
Tokyo, 1 March, 2010 - Daiwa Securities Group, the International Finance Facility for Immunisation Company ("IFFIm"), the GAVI Alliance, and the World Bank have announced today IFFIm's first issue of "Vaccine Bonds" for 2010.
The issue, which is being offered to Japanese retail investors, marks the third issue of Vaccine Bonds arranged by Daiwa, following on from highly successful issues in March 2008 and February 2009.
Health and immunisation programmes
IFFIm, rated AAA/Aaa/AAA, raises funds in the international capital markets to accelerate the availability of funds for health and immunisation programmes in 70 of the poorest countries around the world. IFFIm's financial base consists of legally binding grant payments from its sovereign sponsors (currently France, Italy, Norway, South Africa, Spain, Sweden, the Netherlands, and the United Kingdom).
"We are very pleased to be back in Japan which is not only a world leader in finance and banking but also a nation that has done so much to improve the lives of children in poor countries around the world," said Alan Gillespie, IFFIm's Chairman
The World Bank acts as Treasury Manager for IFFIm. The issue provides Japanese investors with an opportunity to contribute to IFFIm and the funding of immunisation programmes for children in developing countries while investing in high credit quality notes.
The Vaccine Bonds are denominated in South African rand with a maturity of three years. The issuance is arranged by Daiwa Securities Capital Markets Co. Ltd, the wholesale securities firm under the Daiwa Securities Group, and will be distributed by Daiwa Securities Co. Ltd, the Group's retail securities firm, to Japanese retail and institutional investors in March 2010.
Support GAVI Alliance
From its inception in 2006, IFFIm has raised more than US$ 2.3 billion in the capital markets to support GAVI Alliance programmes. GAVI Alliance's mission is to save children's lives and protect people's health by increasing access to immunisation in poor countries.
"IFFIm is an innovative and highly efficient way of raising money for children to be immunised," said Alan Gillespie, IFFIm's Chairman. "We are very pleased to be back in Japan which is not only a world leader in finance and banking but also a nation that has done so much to improve the lives of children in poor countries around the world."
Millennium Development Goal
"GAVI and IFFIm play an important role in international public-private collaboration to reach the Millennium Development Goal to reduce child mortality by two thirds by 2015," said Shigeharu Suzuki, the CEO of Daiwa Securities Group.
"Daiwa is very pleased to contribute to the efforts in delivering the vaccines to the children in the developing countries through our financial capability of bridging investors and people who need capital. Daiwa Securities Group will continuously provide financial products which will enable investors to contribute in solving social problems facing us", .
Summary terms for the new offering are:
| Issuer: | International Finance Facility for Immunisation Company (IFFIm) |
| Issuer rating: | AAA/Aaa/AAA |
| Currency and amount: | ZAR 2.5 billion (USD equivalent 320.5 million) |
| Settlement date: | 23 March 2010 |
| Maturity date: | 27 March 2013 |
| Listing: | Luxembourg |
| Denomination: | ZAR 10,000 |
| Coupon (semi-annual payment): | 7.15% |
* Details of the terms and conditions will be available in the pricing supplement that is to be read in conjunction with IFFIm's most recent base prospectus describing IFFIm's Global Debt Issuance Programme.
About the GAVI Alliance
The GAVI Alliance (formerly the Global Alliance for Vaccines and Immunisation) is a public-private partnership that aims to boost immunisation programmes in more than 70 developing countries. It brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry in both industrialised and developing countries, research and technical agencies, NGOs, the Bill & Melinda Gates Foundation and other private philanthropists. WHO projections from 2000 to 2009 show that through GAVI support 257 million additional children have been vaccinated. This will prevent more than five million premature deaths. GAVI provides vaccines against diphtheria, tetanus, pertussis (DTP) combined with haemophilus influenzae type b (Hib) and hepatitis B in a so-called pentavalent (five antigens in one vaccine). Other vaccines funded by GAVI combat measles, yellow fever, pneumococcal diseases (pneumonia and meningitis) and rotavirus (diarrhoea).
About IFFIm
The International Finance Facility for Immunisation Company (IFFIm) is a multilateral development institution created to accelerate the availability of predictable, long-term funds for health and immunisation programmes through the GAVI Alliance. To date, IFFIm has raised more than US$ 2.3 billion for GAVI programmes. IFFIm's financial base consists of legally binding grant payments from its sovereign sponsors (France, Italy, Norway, South Africa, Spain, Sweden, The Netherlands and the UK), on the basis of which IFFIm issues bonds in the international capital markets. IFFIm is currently rated AAA/Aaa/AAA by Fitch Ratings Limited ("Fitch"), Moody's Investors Service Inc. ("Moody's") and Standard & Poor's Ratings Services ("S&P"). IFFIm was established as a charity with the Charity Commission for England and Wales and is registered in England and Wales as a company limited by guarantee with number 5857343 and as a charity with number 1115413.
About the World Bank
The World Bank is a global development cooperative owned by 186 member countries. Its purpose is to help its members achieve equitable and sustainable economic growth in their national economies and to find effective solutions to pressing regional and global problems in economic development and environmental sustainability. The goal is to help overcome poverty and improve standards of living for people worldwide. The International Bank for Reconstruction and Development (IBRD), rated Aaa/AAA (Moody's/S&P), is the oldest and largest entity in the World Bank Group and provides funding, risk management tools and credit enhancement to sovereigns. To fund this activity, IBRD has been issuing debt securities in the international capital markets for 60 years. The World Bank is also the Treasury Manager for the International Finance Facility for Immunisation (IFFIm). In that capacity, the World Bank, as IFFIm's agent, manages IFFIm's finances according to prudent policies and standards. This includes IFFIm's funding strategy and its implementation in the capital markets, rating agency and investor outreach, hedging transactions and investment management. The World Bank also coordinates with IFFIm's donors and manages their pledges and payments as well as IFFIm's disbursements for immunisation and health programmes through the GAVI Alliance.
About Daiwa Securities Group
Daiwa Securities Group Inc., headquartered in Tokyo, Japan, is the holding company of a group of companies that provides a broad range of investment and financial services. Brokerage of equities, bonds, derivatives and other financial products, investment banking services such as underwriting and M&A advisory, asset management for retail and institutional clients, as well as venture capital and principal investments are included in these services. A total of 16,000 employees work for the Group around the world. Customers' assets under custody totaled JPY42.2 trillion and assets under management of the Group's two asset management companies totaled JPY12.8 trillion as of the end of 2009. The Group has its operational base around the world, including Japan, the US, Europe, and Asia Oceania. Through this global network, the Group provides a broad range of services to fulfill the needs of its clients worldwide.
Media contacts
Rachel Winter Jones
The World Bank (Paris)
Office: +33 1 4069 3052
Yoshiyuki Arima
World Bank
Tel: +81 3 3597 6650
_40.gif)
Masaya Serizawa, Kozue Niida, Takahiro Inoue
Daiwa Securities Capital Markets (Tokyo)
Office: +81 3 5555 3053/39
Kana Shirakawa, Hiroharu Misawa, Yukiko Kishino, Misato Kinoshita
Daiwa Securities Group (Tokyo)
Tel. +81 3 5555 1165
Latest Press releases
- IFFIm issues NOK600 million Vaccine Bonds
- Kingdom of Norway contributes NOK 600 million to IFFIm
- IFFIm issues sukuk to the Islamic Development Bank
- Helge Weiner-Trapness joins IFFIm Board
- Islamic Development Bank and IFFIm announce plans to collaborate on private placement
- Government of Brazil signs grant agreement for US$ 20 million in support to IFFIm
- Bertrand de Mazières joins IFFIm Board
- Cyrus Ardalan becomes new Chair of IFFIm Board
- IFFIm issues US$ 300 million in 3-year floating rate Vaccine Bonds
- IFFIm issues US$ 500 million in 3-year floating rate Vaccine Bonds
Related pages
- IFFIm Vaccine Bonds for Japanese Investors
- Investors get another opportunity to buy vaccine bonds
- IFFIm issues first vaccine bonds of 2011
Disclaimer
THE SECURITIES REFERRED TO IN THIS DOCUMENT HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR UNDER THE SECURITIES LEGISLATION OF ANY STATE OF THE UNITED STATES, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES, OTHER THAN PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. IFFIm DOES NOT PRESENTLY INTEND TO MAKE A PUBLIC OFFER OF SECURITIES IN THE UNITED STATES OR TO REGISTER ANY SECURITIES UNDER THE SECURITIES ACT. ANY OFFERING OF SECURITIES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM IFFIm AND WILL CONTAIN DETAILED INFORMATION ABOUT IFFIm AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS. THE SECURITIES REFERRED TO IN THIS DOCUMENT WILL ONLY BE OFFERED OR SOLD OUTSIDE THE UNITED STATES IN OFFSHORE TRANSACTIONS IN RELIANCE ON REGULATION S UNDER THE SECURITIES ACT.
THIS DOCUMENT IS NOT AN OFFER FOR THE SALE OF SECURITIES. THIS DOCUMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY, THE UNITED STATES
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.